The Peptide Report
A new category of intranasal wellness sprays is quietly reshaping how high-performers wind down at night. Inside the rise of DSIP nasal sprays among executives who refuse to trade tomorrow for tonight.
A growing cohort of founders and venture capitalists have quietly moved away from prescription hypnotics toward a doctor-formulated nasal spray that supports deep sleep architecture. Here's the science — and the cultural shift — behind the swap.
Inside the quiet shift among Silicon Valley operators away from melatonin and toward a nighttime peptide nasal spray. A look at the science, the sleep architecture problem, and the doctor-formulated answer.
From founders to Fortune 500 CEOs, the recovery-obsessed professional class is quietly trading prescription sedatives for a doctor-formulated nasal spray. Here's the science — and the cultural shift — behind the change.
